Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_assertion type Assertion NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_head.
- NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_assertion description "[, the CysLTR1 polymorphism may contribute to develop to the AIA phenotype and be used as a genetic marker for differentiating two major aspirin hypersensitivity phenotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_provenance.
- NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_assertion evidence source_evidence_literature NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_provenance.
- NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_assertion SIO_000772 17641958 NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_provenance.
- NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_assertion wasDerivedFrom gad-20150221 NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_provenance.
- NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_assertion wasGeneratedBy ECO_0000203 NP109299.RAP2YcqzUtxPmATGxEWZn8XuKGjQzVAY99ys2RkF-xBso130_provenance.